TOMI Environmental Solutions Announces the Successful Elimination of Infectious Bacteria and Spores Using Their Ultra-D Technology in a Hospital Operating Room Setting


BEVERLY HILLS, Calif., Oct. 5, 2009 (GLOBE NEWSWIRE) -- In mid-September 2009, TOMI (OTCBB:TOMZ), working with a leading East Coast hospital and a national premier hospital service group, employed its Ultra-D Hydrogen Peroxide based fogging system against challenge plates inoculated with Klebsiella bacteria and Geobacillus Stearothermophilus spores. These Pathogens are much more difficult to kill than MRSA, H1N1 (Swine flu) and C-Diff which are plaguing American schools and hospitals. Assured Biotechnology Labs developed the challenge plates, which is an AIHA accredited, EPA licensed and CDC Elite laboratory.

Klebsiella bacteria and Geobacillus Stearothemophilus spores were used to demonstrate the effectiveness of the Ultra-D technology against drug resistant and spore forming organisms such as MRSA, VRE and C-Diff. Challenge plates were strategically placed throughout the operating room and then exposed to thirty minutes of Ultra-D treatment.

The challenge plates were then incubated for seven days, which revealed a total elimination of both bacterial and spores.

The Ultra-D technology activates Hydrogen Peroxide, which then produces hydroxyl radicals, which kill bacteria, fungi and viruses within seconds of contact. Healthcare facilities worldwide are dealing with an increase in drug resistant pathogens that infect over two million patients in the United States each year. Hospital acquired infections kill 271 people daily, which equates to a major airline crash. The Ultra-D is an emerging technology that provides rapid high-level disinfection while using hydrogen peroxide that leaves no residue, does not damage disposables and is safe for the environment.

About TOMI Environmental Solutions (TOMI(ES))

TOMI Environmental Solutions (OTCBB:TOMZ) is a leading provider of environmental services that are using ozone and activated hydrogen peroxide to achieve a safe and healthy indoor environments. TOMI technicians inspect, test (on a DNA level) and treat indoor air using highly trained, certified technicians who are qualified to assess the air quality of buildings, homes, offices, or vehicles and to clean up the indoor contaminants, pathogens and pollution. Compared to other existing methods of air remediation and purification, TOMI systems produce byproduct-free ozone and activated hydrogen peroxide mist with a high degree of safety and industry expertise. Additionally, to help maintain the clean environment after its deep cleaning, The Company offers its non-ozone producing UV germicidal accessories, including the "Terminator", that can be permanently installed to maintain clean inside air. For more information, visit www.tomiesinc.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.



            

Contact Data